Company intelligence / Profile preview
Eden Biologics, Inc.
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Eden Biologics, formerly JHL Biotech, was a biopharmaceutical company specializing in the development of biosimilars and offering comprehensive CDMO services for large-molecule biologics, from cell line development to commercial manufacturing. The company was acquired by Bora Pharmaceuticals in 2022.
- Therapeutic areas
- PulmonologyOncologyEndocrinologyRheumatologyGastroenterology
- Modalities
- Monoclonal antibodiesBiosimilarsBiological productsEnzymes
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Eden Biologics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eden Biologics, Inc..